All Stocks
A

APLS

Apellis Pharmaceuticals, Inc.
Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$40.41

Market Cap

$5.17B

Beta

0.29

P/E

239.4

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+28.46%
EPS Growth (YoY)+110.69%
Revenue CAGR 3Y+136.98%
P/E Ratio239.4
PEG Ratio2.15
FCF Yield+0.88%
Debt / Equity1.31
Interest Coverage1.3x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for APLS.